{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:50:27Z","timestamp":1784321427759,"version":"3.55.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neuropharm.2016.02.029","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T12:13:29Z","timestamp":1456575209000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PB","title":["The kynurenine pathway and parasitic infections that affect CNS function"],"prefix":"10.1016","volume":"112","author":[{"given":"Nicholas H.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Khoon","family":"Too","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loke Tim","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leia","family":"Hee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges E.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.02.029_bib1","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.144.7.2725","article-title":"Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine","volume":"144","author":"Adams","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib2","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/IAI.70.5.2368-2374.2002","article-title":"Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication","volume":"70","author":"Aline","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fimmu.2014.00485","article-title":"Tryptophan-catabolizing enzymes \u2013 party of three","volume":"5","author":"Ball","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1385-299X(02)00147-2","article-title":"Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection","volume":"9","author":"Ball","year":"2002","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","article-title":"Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway","volume":"41","author":"Ball","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneph0255","article-title":"Parasitic infections in transplant recipients","volume":"2","author":"Barsoum","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-3024.2010.01272.x","article-title":"Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to trichuris muris infection","volume":"33","author":"Bell","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib8","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.tp.0000269199.16209.22","article-title":"Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes","volume":"84","author":"Belladonna","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib9","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.06.063","article-title":"Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice","volume":"139","author":"Bercik","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0169-4758(94)90238-0","article-title":"Cerebral malaria: the sequestration hypothesis","volume":"10","author":"Berendt","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138920007780362527","article-title":"How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation","volume":"8","author":"Boasso","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib12","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.3390\/ijms16059772","article-title":"Changing the face of kynurenines and neurotoxicity: therapeutic considerations","volume":"16","author":"Bohar","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2990.1999.00188.x","article-title":"Evidence of blood\u2013brain barrier dysfunction in human cerebral malaria","volume":"25","author":"Brown","year":"1999","journal-title":"Neuropath Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/IAI.67.5.2233-2240.1999","article-title":"Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK\/STAT pathway","volume":"67","author":"Ceravolo","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib15","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1097\/CCM.0b013e31822827f2","article-title":"Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis","volume":"39","author":"Changsirivathanathamrong","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib16","first-page":"334","article-title":"Toxoplasmosis and pregnancy","volume":"60","author":"Chaudhry","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1521-4141(200102)31:2<333::AID-IMMU333>3.0.CO;2-X","article-title":"IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma","volume":"31","author":"Chaves","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-3024.2008.01068.x","article-title":"Interferon-gamma-mediated activation of enterocytes in immunological control of Encephalitozoon intestinalis infection","volume":"31","author":"Choudhry","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib19","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1073\/pnas.87.7.2506","article-title":"Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases","volume":"87","author":"Christen","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib20","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0169-4758(94)90237-2","article-title":"The cytokine theory of human cerebral malaria","volume":"10","author":"Clark","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.1994.14.313","article-title":"Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells","volume":"14","author":"Dai","year":"1994","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib23","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/IAI.73.7.4025-4033.2005","article-title":"Identification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasite","volume":"73","author":"Datta","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-1-4615-4709-9_64","article-title":"IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism","volume":"467","author":"Daubener","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-5728(93)90072-7","article-title":"Induction of toxoplasmostasis in a human glioblastoma by interferon gamma","volume":"43","author":"Daubener","year":"1993","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004300050086","article-title":"Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production","volume":"187","author":"Daubener","year":"1999","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/eji.1830260231","article-title":"Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha","volume":"26","author":"Daubener","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib28","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/IAI.69.10.6527-6531.2001","article-title":"Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase","volume":"69","author":"Daubener","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/icb.1997.80","article-title":"Inhibition of Toxoplasma gondii replication in IFN-gamma-activated human intestinal epithelial cells","volume":"75","author":"Dimier","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2567.1998.00553.x","article-title":"Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron","volume":"94","author":"Dimier","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/jir621","article-title":"Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection","volume":"205","author":"Divanovic","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1550-7408.1985.tb03013.x","article-title":"Nutritional requirements of plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth","volume":"32","author":"Divo","year":"1985","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4269\/ajtmh.2000.62.284","article-title":"Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?","volume":"62","author":"Dobbie","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-3024.2012.01380.x","article-title":"Indoleamine 2,3-dioxygenase (IDO) induced by leishmania infection of human dendritic cells","volume":"34","author":"Donovan","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ijpara.2009.01.005","article-title":"History of the discovery of the life cycle of Toxoplasma gondii","volume":"39","author":"Dubey","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib36","first-page":"103","article-title":"Experimental models of cerebral malaria","volume":"297","author":"Engwerda","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2015.02.028","article-title":"Neurobiological studies on the relationship between toxoplasmosis and neuropsychiatric diseases","volume":"351","author":"Fabiani","year":"2015","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pt.2013.01.007","article-title":"How and why toxoplasma makes us crazy","volume":"29","author":"Flegr","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.167.3919.893","article-title":"Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts","volume":"167","author":"Frenkel","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib41","article-title":"L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences","author":"Fujigaki","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.70.2.779-786.2002","article-title":"L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase","volume":"70","author":"Fujigaki","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0974-777X.83536","article-title":"Toxoplasmosis: a global threat","volume":"3","author":"Furtado","year":"2011","journal-title":"J.\u00a0Glob. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0169-4758(94)90236-4","article-title":"Cerebral malaria: mediators, mechanical obstruction or more?","volume":"10","author":"Grau","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib45","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.86.14.5572","article-title":"Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumour necrosis factor","volume":"86","author":"Grau","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.01.004","article-title":"Prenatal depression and anxiety in Toxoplasma gondii-positive women","volume":"204","author":"Groer","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-065X.2010.00915.x","article-title":"Control of immune response by amino acid metabolism","volume":"236","author":"Grohmann","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pt.2012.01.002","article-title":"Malaria's deadly secret: a skin stage","volume":"28","author":"Guilbride","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib49","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib52","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.62.6.2277-2284.1994","article-title":"Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts","volume":"62","author":"Gupta","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib53","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/IAI.61.5.1810-1813.1993","article-title":"Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase","volume":"61","author":"Habara-Ohkubo","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib54","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1128\/IAI.66.10.4989-4993.1998","article-title":"Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes","volume":"66","author":"Halonen","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib55","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/IAI.68.6.3426-3430.2000","article-title":"Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes","volume":"68","author":"Halonen","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib56","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ijpara.2004.07.008","article-title":"Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium","volume":"34","author":"Hansen","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/pim.12163","article-title":"Toxoplasma gondii dissemination: a parasite's journey through the infected host","volume":"37","author":"Harker","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000180267","article-title":"Neuropsychiatric disease and Toxoplasma gondii infection","volume":"16","author":"Henriquez","year":"2009","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.2007.00374.x","article-title":"Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation","volume":"52","author":"Heseler","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410290215","article-title":"Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status","volume":"29","author":"Heyes","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib62","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1471-4159.1988.tb01183.x","article-title":"Systemic lipopolysaccharide and pokeweed mitogen increase quinolinic acid content of mouse cerebral cortex","volume":"51","author":"Heyes","year":"1988","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(89)90101-7","article-title":"Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex","volume":"491","author":"Heyes","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.410260215","article-title":"Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome","volume":"26","author":"Heyes","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0022-510X(95)00164-W","article-title":"Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children","volume":"133","author":"Heyes","year":"1995","journal-title":"J.\u00a0Neurological Sci."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib67","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/schbul\/sbm010","article-title":"A\u00a0controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence","volume":"33","author":"Hinze-Selch","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9394(99)00263-9","article-title":"Reconsidering the pathogenesis of ocular toxoplasmosis","volume":"128","author":"Holland","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib69","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/emmm.201202273","article-title":"Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria","volume":"5","author":"Howland","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fcimb.2014.00113","article-title":"Cerebral malaria: gamma-interferon redux","volume":"4","author":"Hunt","year":"2014","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","article-title":"Immunopathogenesis of cerebral malaria","volume":"36","author":"Hunt","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1471-4906(03)00229-1","article-title":"Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria","volume":"24","author":"Hunt","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1863-2378.2009.01276.x","article-title":"A\u00a0brief history and overview of Toxoplasma gondii","volume":"57","author":"Innes","year":"2010","journal-title":"Zoonoses Public Health"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2016.02.029_bib75","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1093\/clinids\/17.Supplement_2.S423","article-title":"Toxoplasmosis in patients with cancer","volume":"17","author":"Israelski","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.01066-15","article-title":"Benzo[b]quinolizinium derivatives have a strong antimalarial activity and inhibit indoleamine dioxygenase","volume":"60","author":"Jortzik","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib77","series-title":"Cell\u2013cell Interactions in a Model of Cerebral Malaria","author":"Khaw","year":"2012"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib78","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1096\/fj.09-150920","article-title":"Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi","volume":"24","author":"Knubel","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib79","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"IDO expression in the brain: a double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J.\u00a0Mol. Med. Berl."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-0135-0_13","article-title":"IDO (indolamine 2,3-dioxygenase) expression and function in the CNS","volume":"527","author":"Kwidzinski","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib81","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0900408","article-title":"Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression","volume":"183","author":"Liu","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib82","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.4049\/jimmunol.178.7.4260","article-title":"Suppression of memory CD8 T cell generation and function by tryptophan catabolism","volume":"178","author":"Liu","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/138920007780362518","article-title":"Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines","volume":"8","author":"MacKenzie","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib84","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3254::AID-IMMU3254>3.0.CO;2-0","article-title":"Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis","volume":"29","author":"MacKenzie","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2015.11.005","article-title":"Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice","volume":"298","author":"Mahmoud","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.0.CO;2-E","article-title":"Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier","volume":"16","author":"Medana","year":"1996","journal-title":"GLIA"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib87","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/377583","article-title":"Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria","volume":"188","author":"Medana","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib88","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/339009","article-title":"The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria","volume":"185","author":"Medana","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-0135-0_3","article-title":"Tryptophan catabolism and T cell responses","volume":"527","author":"Mellor","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib90","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.170.12.5809","article-title":"Tryptophan catabolism and regulation of adaptive immunity","volume":"170","author":"Mellor","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijpara.2008.10.005","article-title":"Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria","volume":"39","author":"Miu","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib92","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/eri.12.58","article-title":"Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment","volume":"10","author":"Moncada","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib93","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.4049\/jimmunol.134.3.1982","article-title":"Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii","volume":"134","author":"Murray","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib94","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/IAI.57.3.845-849.1989","article-title":"Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages","volume":"57","author":"Murray","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib95","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/IAI.00416-13","article-title":"Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication","volume":"81","author":"Niedelman","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib96","article-title":"Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders","author":"O'Farrell","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4615-0135-0_2","article-title":"Role of IDO activation in anti-microbial defense in human native astrocytes","volume":"527","author":"Oberdorfer","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib98","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpsychires.2015.10.002","article-title":"Combined Toxoplasma gondii seropositivity and high blood kynurenine - linked with nonfatal suicidal self-directed violence in patients with schizophrenia","volume":"72","author":"Okusaga","year":"2016","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib99","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.placenta.2005.06.006","article-title":"BeWo trophoblasts are unable to control replication of Toxoplasma gondii, even in the presence of exogenous IFN-gamma","volume":"27","author":"Oliveira","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7861\/clinmedicine.8-5-539","article-title":"Common AIDS-associated opportunistic infections","volume":"8","author":"Ong","year":"2008","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib101","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2119\/molmed.2012.00029","article-title":"Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase","volume":"18","author":"Orabona","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib102","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood\u2013brain-barrier cells: implications for immune tolerance and neurotoxicity","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2040-7378-4-24","article-title":"Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia","volume":"4","author":"Padberg","year":"2012","journal-title":"Exp. Transl. Stroke Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib104","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib106","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0166-6851(86)90101-5","article-title":"Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan","volume":"20","author":"Pfefferkorn","year":"1986","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib107","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/MMBR.00027-15","article-title":"Long-term relationships: the complicated interplay between the host and the developmental stages of toxoplasma gondii during acute and chronic infections","volume":"79","author":"Pittman","year":"2015","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mehy.2014.04.018","article-title":"A\u00a0new hypothesis on preventable neuropsychiatric illness in Africa","volume":"83","author":"Pollach","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijpara.2006.02.007","article-title":"Pathogenic T cells in cerebral malaria","volume":"36","author":"Renia","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"Reus","year":"2015","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib111","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib112","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/brain\/awp074","article-title":"Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis","volume":"132","author":"Rodgers","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib113","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","article-title":"The economic and social burden of malaria","volume":"415","author":"Sachs","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/00207459208994781","article-title":"L-tryptophan in neuropsychiatric disorders: a review","volume":"67","author":"Sandyk","year":"1992","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0002-9440(10)61786-5","article-title":"Is ischemia involved in the pathogenesis of murine cerebral malaria?","volume":"159","author":"Sanni","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib116","first-page":"611","article-title":"Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria","volume":"152","author":"Sanni","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib117","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/mi.2013.115","article-title":"Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNgamma-regulated host pathways for the parasite development","volume":"7","author":"Schmid","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib118","doi-asserted-by":"crossref","first-page":"20197","DOI":"10.1074\/jbc.M112.351999","article-title":"Apicomplexan parasite, eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse","volume":"287","author":"Schmid","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib119","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/eji.200939535","article-title":"Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase","volume":"39","author":"Schmidt","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/IAI.70.2.859-868.2002","article-title":"Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in\u00a0vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1","volume":"70","author":"Silva","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib121","article-title":"Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors","author":"Smith","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib122","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1179\/135100004225006001","article-title":"Quinolinic acid induces NMDA receptor-mediated lipid peroxidation in rat brain microvessels","volume":"9","author":"St'astny","year":"2004","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0361-9230(00)00368-3","article-title":"Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin","volume":"53","author":"St'astny","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib124","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02815173","article-title":"Biochemical characteristics of gamma-glutamyl transpeptidase in capillaries from entorhinohippocampal complex of quinolinate-lesioned rat brain","volume":"32","author":"Stastny","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-0082(00)00032-0","article-title":"Kynurenines in the CNS: from endogenous obscurity to therapeutic importance","volume":"64","author":"Stone","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib127","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2001-3401","article-title":"The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines","volume":"3","author":"Stone","year":"2001","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib128","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.4049\/jimmunol.150.12.5529","article-title":"IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular chlamydia spp. or toxoplasma growth","volume":"150","author":"Thomas","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1017\/S0031182000080203","article-title":"Breakdown of the blood\u2013brain barrier in murine cerebral malaria","volume":"96","author":"Thumwood","year":"1988","journal-title":"Parasitology"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00430-003-0210-1","article-title":"Enhancement of antimicrobial effects by glucocorticoids","volume":"194","author":"Turck","year":"2005","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib131","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-4615-4709-9_65","article-title":"Importance of L-tryptophan metabolism in trypanosomiasis","volume":"467","author":"Vincendeau","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib132","series-title":"WHO Guidelines Approved By The Guidelines Review Committee. Guidelines for the Treatment of Malaria","author":"W.H.O","year":"2015"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib133","series-title":"World Malaria Report 2015","author":"W.H.O","year":"2015"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib134","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.14411\/fp.2010.012","article-title":"Toxoplasma gondii-altered host behaviour: clues as to mechanism of action","volume":"57","author":"Webster","year":"2010","journal-title":"Folia Parasitol. (Praha)"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib136","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib137","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4049\/jimmunol.147.6.2019","article-title":"Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts","volume":"147","author":"Woodman","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2016.02.029_bib138","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"13","author":"Yolken","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.029_bib139","doi-asserted-by":"crossref","first-page":"20110375","DOI":"10.1098\/rstb.2011.0375","article-title":"The effect of raising and lowering tryptophan levels on human mood and social behaviour","volume":"368","author":"Young","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:08:34Z","timestamp":1748790514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816300648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":139,"alternative-id":["S0028390816300648"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kynurenine pathway and parasitic infections that affect CNS function","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}